Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

27.94
-0.1500-0.53%
Pre-market: 27.67-0.2700-0.97%09:11 EST
Volume:3.19M
Turnover:88.37M
Market Cap:3.14B
PE:-27.70
High:28.30
Open:28.18
Low:26.97
Close:28.09
Loading ...

Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”

Insider Monkey
·
02 Feb

Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’

Insider Monkey
·
31 Jan

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Zacks
·
31 Jan

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks
·
30 Jan

How to Play NVO Stock After New Drug's Success in Obesity Study

Zacks
·
29 Jan

B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
28 Jan

Institutional investors control 73% of Viking Therapeutics, Inc. (NASDAQ:VKTX) and were rewarded last week after stock increased 5.7%

Simply Wall St.
·
27 Jan

Viking Therapeutics (VKTX) Stock Could Rise 200%, Says Jefferies

TIPRANKS
·
24 Jan

Promising Clinical Developments and Strategic Initiatives Drive Buy Rating for Viking Therapeutics

TIPRANKS
·
23 Jan

GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise

Zacks
·
22 Jan

Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks
·
22 Jan

What's next for Viking Therapeutics? Here's how the company can scale up.

Dow Jones
·
22 Jan

Viking Therapeutics Shares Spike Higher; Last up 3.4%

THOMSON REUTERS
·
22 Jan

Viking Therapeutics’ Clinical Advancements and Strategic Partnerships Boost Buy Rating

TIPRANKS
·
21 Jan

Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week

Insider Monkey
·
20 Jan

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Jan